Rainier Clinical Research Center, a US-based healthcare and clinical research facility specializing in diabetes and medical device trials, was allegedly targeted in a ransomware attack by the incransom group. A leak site claim was posted on February 23, 2026, by incransom, threatening to publish exfiltrated data. As of the available information, there has been no official confirmation from Rainier Clinical Research Center regarding this incident, nor have any official breach notifications been issued. The alleged attack remains unverified by the company or authorities.
The specific types of data exposed, the number of individuals affected, and the states impacted have not been disclosed or publicly confirmed. Given the nature of Rainier Clinical Research Center's operations, potential risks may include personal identifying information and medical/health-related data, though this remains unconfirmed. There is no information confirming the involvement of SSN, financial data, or specific medical records.
Details surrounding this alleged data breach are still preliminary, and further information may emerge as the situation develops. Official notices from the company have not been released, and no Attorney General filings have been reported.